Warsaw Medical Physics Meeting 2015
14-05-2015 09:00 to 16-05-2015 16:00
Center of New Technologies
- 14-05-2015 09:45
The development of biological targeting agents such as proteins, peptides, antibodies and nanoparticles contributing in vivo processes lasting many hours and days demands the production of radionuclides with radioactive half-lives complementary to these biological properties. Potentially useful radiometals include nuclides such as Zirconium 89 (89Zr), Yttrium 86 (86Y) and Copper 64 (64Cu). In the presented project, optimal methods of cyclotron target production for these radiometals...
- 14-05-2015 12:00
Andrzej Wojcik1, Iuliana Toma-Dasu2 and Alexandru Dasu3 1: Centre for Radiation Protection Research, MBW Department, Stockholm University; 2: Medical Radiation Physics, Department of Physics, Stockholm University; 3: Department of Radiation Physics and Department of Medical and Health Sciences, Linköping University and Skandionkliniken, Uppsala, Sweden. Nearly two-thirds of all cancer patients will receive radiation therapy during their illness. But ionising radiation is a two-edged sword: ...
Professional profile of Portuguese Radiation Therapists, competence related professional issues linked to ESTRO RTT core curriculum
- 15-05-2015 10:50
Background and Purpose: The continuous development and innovations in Radiation Oncology requires well trained and specialized practitioners. Among the multidisciplinary team, the Radiation Therapist (RTT) requires adequate knowledge and skills, to develop clearer and well defined roles, professionalism and clinical competences within the field of practice. The Core Curriculum (CC) recommended by ESTRO was published to promote and establish a standard that should be recognized and used by Europe...
- 16-05-2015 11:35
Recombination chambers give possibility to perform measurements for various purposes of radiation protection of patient, medical personnel, bystanders and other people. Radiation protection with help of large tissue equivalent detectors gives not only dose but also ambient dose equivalent. Secondary cancer risk of not treated organs could be recognized with small in-phantom chambers or ring-shape recombination chamber specially designed for dose delivered to optic nerve in proton-eye-therapy. An...